Common Stock and Stock Options | Note 4. Common Stock and Stock Options Stock Based Compensation cost for all stock awards is based on the grant date fair value and recognized over the required service (vesting) period. Noncash stock-based compensation expense was $8,675 and $31,182 for the three months ended June 30, 2021, and 2020, respectively. Noncash stock-based compensation expense was $30,563 and $62,362 for the six months ended June 30, 2021, and 2020, respectively. Unrecognized stock-based compensation expense was $8,669 as of June 30, 2021, and will be recognized through 2023. There was no tax benefit recorded for this compensation cost as the expense primarily relates to incentive stock options that do not qualify for a tax deduction until, and only if, a qualifying disposition occurs. The non-employee Board members received compensation of 5,265 and 51,085 aggregate shares of common stock of the Company during the six months ended June 30, 2021, and 2020, respectively. The stock had an aggregate value of $14,987 and $59,998 for the six months ended June 30, 2021, and 2020, respectively, and was recorded as noncash stock-based compensation expense in the financial statements. Employees received compensation of 4,804 aggregate shares of common stock of the Company during the six months ended June 30, 2021, which had an aggregate value of $13,211, and was recorded as noncash stock-based compensation expense in the financial statements. In addition, during the six months ended June 30, 2021, a total of 30,181 stock options were exercised by management. The cumulative status of options granted and outstanding at June 30, 2021, and December 31, 2020, as well as options which became exercisable in connection with the Company’s stock option plans is summarized as follows: Note 4. Common Stock and Stock Options (continued) Employee Stock Options Weighted Average Stock Options Exercise Price Outstanding at January 1, 2020 76,037 $ 1.03 Outstanding at December 31, 2020 76,037 $ 1.03 Exercised (30,181) 0.96 Outstanding at June 30, 2021 45,856 $ 1.07 Options exercisable at December 31, 2020 55,208 $ 0.94 Options exercisable at June 30, 2021 31,970 $ 0.99 Exercise prices for options ranged from $0.84 to $1.25 at June 30, 2021. The weighted average option price for all options outstanding at June 30, 2021, was $1.07 with a weighted average remaining contractual life of 5.3 years. There were no non-employee director stock options outstanding during 2021 and 2020. |